Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008 Dec 15;47(12):e97-9
Date
11/11/2008Pubmed ID
18991509Pubmed Central ID
PMC2941349DOI
10.1086/593314Scopus ID
2-s2.0-56749153964 (requires institutional sign-in at Scopus site) 37 CitationsAbstract
We report the first case of a human immunodeficiency virus type 1 (HIV-1)-infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections. This case highlights the potential of ritonavir interactions even with local injections of a corticosteroid.
Author List
Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli FAuthor
Kristin Busse PharmD Assistant Professor in the School of Pharmacy Administration department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultCushing Syndrome
Drug Interactions
HIV Infections
HIV-1
Humans
Iatrogenic Disease
Lopinavir
Male
Pyrimidinones
Ritonavir
Triamcinolone